Leaf4life Inc
A Phase 2/3 hypoxia drug designed to use in combination with, to complement, existing therapies for the treating of Acute Respiratory Distress Syndrome (ARDS), hard to treat cancers, and cardiovascular indications that serve a $300Bn+ market.
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
1
11 to 50 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Leaf4life Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
Showing 1 of 1 verified contacts
Top roles at Leaf4life Inc
1 distinct titles indexed · top 1 shown.
- 1founder, chairman & ceo
Sign up to unlock all 1 contacts at Leaf4life Inc
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Leaf4life Inc
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.